Product Images Bludigo

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Bludigo NDC 81284-315 by Provepharm Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - ic1

image description - ic1

Carton Label - ic3

Carton Label - ic3

Bludigo is an injectable medication used intravenously. The medication is indigotindisulfonate sodium injection, USP with 40 mg/5 mL (8 mg/m). Each single dose ampule contains 5mL and 8 mg sodium. The medication is manufactured by CENEXI in France and distributed by Provepharm. The dosage of the medication should be as per the prescribing information enclosed. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from light. Any unused portion of the medication should be discarded.*

Vial Label - ic4

Vial Label - ic4

Bludigom is a medication available in an injectable form intended for intravenous use only. It contains 40mg/5mL of indigotindisulfonate sodium and is sold in single-dose ampules. The medication is manufactured by CENEXI for PROVEPHARM SAS and distributed by PROVEPHARM, INC., with its address at 100 Springhouse Drive, Suite 105, Collegeville, PA 19426. It is Rx only and must be discarded after use. The lot number and expiration date provided is Lot EXP TN (01)00381284315005 Rev_07/2022.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.